Intercept Pharmaceuticals Recognizes International PBC Day
The company's lead product candidate, obeticholic acid (OCA), is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR). OCA is being developed for a variety of chronic liver diseases including primary biliary cirrhosis (PBC), ...
MarketWatch - Fri, 12 Sep 2014 03:56

International PBC Day Is 14 September
Marketwired (press release) - Thu, 11 Sep 2014 23:56

Developments in Approaches to Liver Resection
Open procedures are more often undertaken for disease that is more advanced or for resections that are more difficult technically than is generally undertaken laparoscopically. High-quality prospective data are not available to adequately ...
General Surgery News - Tue, 23 Sep 2014 06:41

Shortage of donors a challenge for liver transplants in PHL
Lecasa also shared that hepatotoxicity or liver damage caused by a drug or chemical is also another cause of liver failure. Biliary atresia, which is a rare disease among infants, and liver cancer can also cause liver impairment that may lead to ...
GMA News - Thu, 18 Sep 2014 00:40



A Life Saving Discovery In LIVER DISORDERS
Other causes include hepatitis C infection, primary biliary cirrhosis, and liver damage caused by occupational chemicals and many medicinal drugs. Certain amino acids have found to play a promising role in preventing and treating a majority of these ...
India PRwire (press release) - Thu, 18 Sep 2014 04:15

160 gastroenterologists to know – 2014
He specializes in diseases of the gastrointestinal tract, liver and pancreas and has a special interest in inflammatory bowel disease and motility disorders of the esophagus. ... in Rockville, Md. He has previously served as chief of the ...
Becker's Hospital Review - Thu, 18 Sep 2014 15:18

Local woman celebrates 20th anniversary of organ transplant
The disease slowly destroys bile ducts, prohibiting bile — a fluid produced in the liver — from digesting food and helping rid the body of worn-out red blood cells, cholesterol and toxins. As a result, harmful substances can build in the liver and ...
Huntington Herald Dispatch - Sat, 06 Sep 2014 20:11



New Guideline Addresses Management of Focal Liver Lesions
... noncancerous lesions such as hepatocellular adenomas and biliary cystadenomas have malignant potential. These lesions may not necessarily present with symptoms attributable to the lesion and are frequently not associated with underlying liver disease.
Medscape - Mon, 25 Aug 2014 13:03

Intercept to Present at Upcoming Investor Conferences
The company's lead product candidate, obeticholic acid (OCA), is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR). OCA is being developed for a variety of chronic liver diseases including primary biliary cirrhosis (PBC), ...
MarketWatch - Tue, 26 Aug 2014 05:06


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014